260 related articles for article (PubMed ID: 23853056)
1. Association between metformin use and risk of prostate cancer and its grade.
Margel D; Urbach D; Lipscombe LL; Bell CM; Kulkarni G; Austin PC; Fleshner N
J Natl Cancer Inst; 2013 Aug; 105(15):1123-31. PubMed ID: 23853056
[TBL] [Abstract][Full Text] [Related]
2. Metformin use and prostate cancer risk.
Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
[TBL] [Abstract][Full Text] [Related]
3. The use of metformin in patients with prostate cancer and the risk of death.
Bensimon L; Yin H; Suissa S; Pollak MN; Azoulay L
Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):2111-8. PubMed ID: 25017246
[TBL] [Abstract][Full Text] [Related]
4. Predictors of emergency department and outpatient visits for hypoglycemia in type 2 diabetes: an analysis of a large US administrative claims database.
Simeone JC; Quilliam BJ
Ann Pharmacother; 2012 Feb; 46(2):157-68. PubMed ID: 22234990
[TBL] [Abstract][Full Text] [Related]
5. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
Tseng CH
Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
[TBL] [Abstract][Full Text] [Related]
6. Metformin use and risk of prostate cancer: results from the REDUCE study.
Feng T; Sun X; Howard LE; Vidal AC; Gaines AR; Moreira DM; Castro-Santamaria R; Andriole GL; Freedland SJ
Cancer Prev Res (Phila); 2015 Nov; 8(11):1055-60. PubMed ID: 26353947
[TBL] [Abstract][Full Text] [Related]
7. Type of diabetes mellitus and the odds of Gleason score 8 to 10 prostate cancer.
Kang J; Chen MH; Zhang Y; Moran BJ; Dosoretz DE; Katin MJ; Braccioforte MH; Salenius SA; D'Amico AV
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e463-7. PubMed ID: 21944463
[TBL] [Abstract][Full Text] [Related]
8. Metformin and the incidence of prostate cancer in patients with type 2 diabetes.
Azoulay L; Dell'Aniello S; Gagnon B; Pollak M; Suissa S
Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):337-44. PubMed ID: 21148757
[TBL] [Abstract][Full Text] [Related]
9. Neither diabetes nor glucose-lowering drugs are associated with mortality after noncardiac surgery in patients with coronary artery disease or heart failure.
Hanninen M; McAlister FA; Bakal JA; van Diepen S; Ezekowitz JA
Can J Cardiol; 2013 Apr; 29(4):423-8. PubMed ID: 22985785
[TBL] [Abstract][Full Text] [Related]
10. The risk of prostate cancer for men on aspirin, statin or antidiabetic medications.
Nordström T; Clements M; Karlsson R; Adolfsson J; Grönberg H
Eur J Cancer; 2015 Apr; 51(6):725-33. PubMed ID: 25727881
[TBL] [Abstract][Full Text] [Related]
11. Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes.
Margel D; Urbach DR; Lipscombe LL; Bell CM; Kulkarni G; Austin PC; Fleshner N
J Clin Oncol; 2013 Sep; 31(25):3069-75. PubMed ID: 23918942
[TBL] [Abstract][Full Text] [Related]
12. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial.
Gong Z; Neuhouser ML; Goodman PJ; Albanes D; Chi C; Hsing AW; Lippman SM; Platz EA; Pollak MN; Thompson IM; Kristal AR
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1977-83. PubMed ID: 17035408
[TBL] [Abstract][Full Text] [Related]
13. Association between Metformin Use and Cancer Stage at Diagnosis among Elderly Medicare Beneficiaries with Preexisting Type 2 Diabetes Mellitus and Incident Prostate Cancer.
Raval AD; Mattes MD; Madhavan S; Pan X; Wei W; Sambamoorthi U
J Diabetes Res; 2016; 2016():2656814. PubMed ID: 27547763
[TBL] [Abstract][Full Text] [Related]
14. The influence of antidiabetic medications on the development and progression of prostate cancer.
Hitron A; Adams V; Talbert J; Steinke D
Cancer Epidemiol; 2012 Aug; 36(4):e243-50. PubMed ID: 22417708
[TBL] [Abstract][Full Text] [Related]
15. Metformin does not alter the risk of lung cancer: a case-control analysis.
Bodmer M; Becker C; Jick SS; Meier CR
Lung Cancer; 2012 Nov; 78(2):133-7. PubMed ID: 22959242
[TBL] [Abstract][Full Text] [Related]
16. Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: A population based case-control study.
Brauchli YB; Jick SS; Curtin F; Meier CR
J Am Acad Dermatol; 2008 Mar; 58(3):421-9. PubMed ID: 18194825
[TBL] [Abstract][Full Text] [Related]
17. Obesity, adipokines, and prostate cancer in a prospective population-based study.
Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
[TBL] [Abstract][Full Text] [Related]
18. Effects of diabetes mellitus and Metformin administration on prostate cancer detection at biopsy among Chinese men: a case-control study.
Hu MB; Bai PD; Wu YS; Zhang LM; Zhu WH; Hu JM; Yang T; Jiang HW; Ding Q
J BUON; 2019; 24(1):227-232. PubMed ID: 30941974
[TBL] [Abstract][Full Text] [Related]
19. Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: a population-based nested case-control study.
Weir MA; Gomes T; Mamdani M; Juurlink DN; Hackam DG; Mahon JL; Jain AK; Garg AX
Nephrol Dial Transplant; 2011 Jun; 26(6):1888-94. PubMed ID: 20974644
[TBL] [Abstract][Full Text] [Related]
20. Metformin and the risk of prostate cancer across racial/ethnic groups: a population-based cohort study.
Chen CB; Eurich DT; Majumdar SR; Johnson JA
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):122-126. PubMed ID: 28071672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]